Judo Bio
PrivateLast Round
Series A
Oct 7, 2024
Total Funding Raised
$100M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Judo Bio is a biotechnology company that develops oligonucleotide therapies for systemic and renal diseases by pairing gene-silencing nucleic acids with targeting molecules for specific kidney cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Judo Bio Comparables
Compare Judo Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Borealis Biosciences | 91% | |
| Hybridize Therapeutics | 82% | |
| Rigerna Therapeutics | 79% |
Judo Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 7, 2024 | ||||
| Seed | Oct 7, 2024 |
Judo Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series A, Seed |
| Digitalis Ventures | Series A |
| YK Bioventures | Series A |
| Droia Ventures | Series A |
| The Chernin Group | Series A, Seed |
| The Chatterjee Group | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 38% MoM.
- Oct 7, 2024
$100M round led by Euclidean Capital, The Chatterjee Group, The Chernin Group, Atlas Venture, and Droia Ventures.
Judo Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Judo Bio's valuation, stock price, and market status.
Is Judo Bio a public or private company?
Judo Bio is a private company.
What is the current stock price of Judo Bio?
Judo Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Judo Bio worth (valuation)?
Valuation information for Judo Bio is not publicly available.
Can I buy Judo Bio stock?
Judo Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Judo Bio's last funding round?
Judo Bio's most recent funding round was Series A on October 7, 2024.
Who are the main investors in Judo Bio?
Key investors in Judo Bio include Droia Ventures, The Chernin Group, The Chatterjee Group, Atlas Venture, Euclidean Capital.
Will Judo Bio IPO soon?
No public IPO plans have been announced for Judo Bio.
How can I track Judo Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Judo Bio's secondary market activity and sign up for updates.